Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Long-Term Deferred Tax (2016 - 2025)

Conmed (CNMD) has disclosed Long-Term Deferred Tax for 15 consecutive years, with $13.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Long-Term Deferred Tax rose 20.24% year-over-year to $13.3 million, compared with a TTM value of $13.3 million through Dec 2025, up 20.24%, and an annual FY2025 reading of $13.3 million, up 20.24% over the prior year.
  • Long-Term Deferred Tax was $13.3 million for Q4 2025 at Conmed, up from $11.1 million in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $13.3 million in Q4 2025 and bottomed at $9.6 million in Q4 2022.
  • Average Long-Term Deferred Tax over 5 years is $11.0 million, with a median of $11.1 million recorded in 2024.
  • The sharpest move saw Long-Term Deferred Tax soared 41.14% in 2021, then decreased 1.27% in 2024.
  • Year by year, Long-Term Deferred Tax stood at $9.7 million in 2021, then decreased by 0.07% to $9.6 million in 2022, then increased by 16.18% to $11.2 million in 2023, then dropped by 1.27% to $11.1 million in 2024, then increased by 20.24% to $13.3 million in 2025.
  • Business Quant data shows Long-Term Deferred Tax for CNMD at $13.3 million in Q4 2025, $11.1 million in Q4 2024, and $11.2 million in Q4 2023.